Science Explorer Back to mapMap
Discussion
Researcher · Rocky Mountain Cancer Centers · United States

David Jacob Andorsky

David Jacob Andorsky publishes mostly in Oncology, Genetics and Pathology and Forensic Medicine, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.

ORCID 0000-0002-5699-4644 OpenAlex
World rank
#1,451,763
of 7,710,434 ranked researchers
Rank in United States
#456,756
of 1,627,098
Works
129
Citations
2.6k
Citations per work
20.0
h-index
20
i10-index 34Top 23% in Oncology
David Jacob Andorsky

What does David Jacob Andorsky research?

David Jacob Andorsky's work is mostly in Medicine (80%).

Health Sciences: 103 works · 79.5% of their workMedicine: 103 works · 79.5% of their workOncology: 25 works · 19.4% of their workGenetics: 24 works · 18.6% of their workPathology and Forensic Medicine: 22 works · 17.4% of their workHematology: 16 works · 12.5% of their workPulmonary and Respiratory Medicine: 12 works · 9.0% of their workPublic Health, Environmental and Occupational Health: 3 works · 2.6% of their workEverything else: 26 works · 20.5% of their workTHEIR WORKDavid JacobAndorsky129works
Health Sciences80%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine10379.5%
  2. Everything else2620.5%
  1. 1Oncology19% of their works
  2. 2Genetics19% of their works
  3. 3Pathology and Forensic Medicine17% of their works
  4. 4Hematology12% of their works
  5. 5Pulmonary and Respiratory Medicine9% of their works
  6. 6Public Health, Environmental and Occupational Health3% of their works

Research topics

Which keywords describe David Jacob Andorsky's research?

The keywords of their largest research topics: Rituximab, Lymphoma, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Molecular Profiling, BCR-ABL and Imatinib.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Rituximab1202 topics
  2. Lymphoma792 topics
  3. Chronic Lymphocytic Leukemia611 topic
  4. Genomic Aberrations611 topic
  5. Classification591 topic
  6. Molecular Profiling591 topic
  7. BCR-ABL361 topic
  8. Imatinib361 topic
  9. EGFR Mutations231 topic
  10. Targeted Therapy231 topic
  11. CAR T Cells201 topic
  12. Chimeric Antigen Receptor201 topic
  13. Breast Cancer171 topic
  14. HER2171 topic
  15. Epstein-Barr Virus81 topic
  16. Kaposi's Sarcoma81 topic
  17. Immune Checkpoint Blockade61 topic
  18. PD-1 and PD-L161 topic

Where does David Jacob Andorsky work?

David Jacob Andorsky's main affiliation in the publication record is Rocky Mountain Cancer Centers, United States.

How many publications and citations does David Jacob Andorsky have?

OpenAlex counts 129 works and 2,586 citations for David Jacob Andorsky, an h-index of 20, ranking #1,451,763 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about David Jacob Andorsky. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.